Skip to main content
EuBiologics Co., Ltd. logo

EuBiologics Co., Ltd. — Investor Relations & Filings

Ticker · 206650 ISIN · KR7206650004 KO Manufacturing
Filings indexed 425 across all filing types
Latest filing 2023-01-03 Board/Management Inform…
Country KR South Korea
Listing KO 206650

About EuBiologics Co., Ltd.

http://eubiologics.com/eng/

EuBiologics Co., Ltd. is a biopharmaceutical company focused on improving global public health through the development and supply of safe and effective vaccines. The company specializes in preventative vaccines against global pandemics and emerging infectious diseases, with a key product being its oral cholera vaccine. In addition to its vaccine pipeline, EuBiologics provides Contract Research and Manufacturing Organization (CRMO) services. These services cover the development and GMP-compliant production of mammalian cell and microbial-derived biopharmaceuticals, including protein-based therapeutics and antibodies. The company is committed to technological innovation and adhering to international standards to address global health challenges.

Recent filings

Filing Released Lang Actions
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's representative director (CEO). It explicitly lists the 'before' and 'after' status of the representative directors, the reason for the change (resignation), and the effective date. This falls directly under the category of board or management changes.
2023-01-03 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory requirement for directors or major shareholders to disclose changes in their shareholdings, which falls under the 'Director's Dealing' category.
2023-01-03 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory announcement regarding the setting of a record date and shareholder register closure for an upcoming Annual General Meeting (AGM). It does not contain the full meeting materials or proxy statements, but rather serves as a formal notice of the administrative procedure required for the meeting. Given its nature as a regulatory notification of a corporate event, it fits best under the RNS category.
2022-12-13 Korean
투자판단관련주요경영사항(COVID-19 예방 백신 유코백-19 추가접종 1/2상 임상시험계획(IND) 승인)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Eubiologics regarding the approval of a clinical trial (IND) for a COVID-19 vaccine. It is a specific disclosure of a material business event (major management matter) required by the Korea Exchange (KRX). Since it does not fit into specific categories like financial reports, dividends, or M&A, and is a formal regulatory disclosure of a business development, it is classified as a Regulatory Filing (RNS).
2022-12-07 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) and its subsequent amendment (정정신고). It details a contract with UNICEF for vaccine supply. Since this is a specific regulatory disclosure of a material contract event that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2022-12-06 Korean
신규시설투자등(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory disclosure from Eubiologics regarding a new facility investment (capital expenditure) for vaccine production. It details the investment amount, purpose, duration, and funding sources. Since it describes a specific capital investment project rather than a general financing update or a share-related change, and it is a formal regulatory disclosure, it fits best under the 'Regulatory Filings' category as a specific corporate announcement.
2022-11-25 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.